Urinary proteomic profiles distinguish between active and inactive lupus nephritis

Rheumatology

Volumn 45, Issue 12, 2006, Pages 1497-1504

  Mosley, K ^a   Tam, F W K ^a   Edwards, R J ^a   Crozier, J ^a   Pusey, C D ^a   Lightstone, L ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Biomarkers; Lupus nephritis; SELDI TOF MS

Indexed keywords

BIOLOGICAL MARKER; IMMUNOSUPPRESSIVE AGENT; PROTEIN;

ARTICLE; ASSAY; DIAGNOSTIC TEST; DISCRIMINANT ANALYSIS; DISEASE ACTIVITY; DISEASE COURSE; DRUG RESPONSE; DRUG TARGETING; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MULTIPLE REGRESSION; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN URINE LEVEL; PROTEOMICS; RELAPSE; REMISSION; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; URINALYSIS;

ADULT; BIOLOGICAL MARKERS; CREATININE; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PROTEIN ARRAY ANALYSIS; PROTEINURIA; PROTEOMICS; RECURRENCE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33751412843     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kel351     Document Type: Article

References (31)

1. Hill GS, Delahousse M, Nochy D et al. Outcome of relapse in lupus nephritis: Roles of reversal of renal fibrosis and response of inflammation to therapy. Kidney Int 2002;61:2176-86.
2. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975;250:4007-21.
3. Lin D, Tabb DL, Yates JRIII. Large-scale protein identification using mass spectrometry. Biochim Biophys Acta 2003;1646:1-10.
4. Chapman K. The ProteinChip Biomarker System from Ciphergen Biosystems: A novel proteomics platform for rapid biomarker discovery and validation. Biochem Soc Trans 2002;30:82-7.
5. Schaub S, Rush D, Wilkins J et al. Proteomic-based detection of urine proteins associated with acute renal allograft rejection. J Am Soc Nephrol 2004;15:219-27.
6. Clarke W, Silverman BC, Zhang Z, Chan DW, Klein AS, Molmenti EP. Characterization of renal allograft rejection by urinary proteomic analysis. Ann Surg 2003;237:660-4.
7. O'Riordan E, Orlova TN, Mei JJ et al. Bioinformatic analysis of the urine proteome of acute allograft rejection. J Am Soc Nephrol 2004;15:3240-8.
8. Schaub S, Wilkins JA, Antonovici M et al. Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am J Transplant 2005;5:729-38.
9. Hampel DJ, Sansome C, Sha M, Brodsky S, Lawson WE, Goligorsky MS. Toward proteomics in uroscopy: Urinary protein profiles after radiocontrast medium administration. J Am Soc Nephrol 2001;12:1026-35.
10. Cadieux PA, Beiko DT, Watterson JD et al. Surface-enhanced laser desorption/ionization-time of flight-mass spectrometry (SELDI-TOFMS): A new proteomic urinary test for patients with urolithiasis. J Clin Lab Anal 2004;18:170-5.
11. Vlahou A, Schellhammer PF, Mendrinos S et al. Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 2001;158:1491-502.
12. Schaub S, Wilkins J, Weiler T, Sangster K, Rush D, Nickerson P. Urine protein profiling with surface-enhanced laser-desorption/ionization time-of-flight mass spectrometry. Kidney Int 2004;65:323-32.
13. Rogers MA, Clarke P, Noble J et al. Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: Identification of key issues affecting potential clinical utility. Cancer Res 2003;63:6971-83.
14. Cutillas PR, Chalkley RJ, Hansen KC et al. The urinary proteome in Fanconi syndrome implies specificity in the reabsorption of proteins by renal proximal tubule cells. Am J Physiol Renal Physiol 2004;287:F353-64.
15. Norden AG, Lapsley M, Lee PJ et al. Fragmentation of filtered proteins and implications for glomerular protein sieving in Fanconi syndrome. Kidney Int 2002;62:349.
16. Norden AG, Lapsley M, Lee PJ et al. Glomerular protein sieving and implications for renal failure in Fanconi syndrome. Kidney Int 2001;60:1885-92.
17. Nguyen MT, Ross GF, Dent CL, Devarajan P. Early prediction of acute renal injury using urinary proteomics. Am J Nephrol 2005;25:318-26.
18. Gudehithlu KP, Pegoraro AA, Dunea G, Arruda JA, Singh AK. Degradation of albumin by the renal proximal tubule cells and the subsequent fate of its fragments. Kidney Int 2004;65:2113-22.
19. Hilliard LM, Osicka TM, Clavant SP, Robinson PJ, Nikolic-Paterson DJ, Comper WD. Characterization of the urinary albumin degradation pathway in the isolated perfused rat kidney. J Lab Clin Med 2006;147:36-44.
20. Strong KJ, Osicka TM, Comper WD. Urinary-peptide excretion by patients with and volunteers without diabetes. J Lab Clin Med 2005;145:239-46.
21. Singh A, Gudehithlu KP, Le G et al. Decreased urinary peptide excretion in patients with renal disease. Am J Kidney Dis 2004;44:1031-8.
22. Burne MJ, Panagiotopoulos S, Jerums G, Comper WD. Alterations in renal degradation of albumin in early experimental diabetes in the rat: A new factor in the mechanism of albuminuria. Clin Sci 1998;95:67-72.
23. Mehta AI, Ross S, Lowenthal MS et al. Biomarker amplification by serum carrier protein binding. Dis Markers 2003;19:1-10.
24. Lowenthal MS, Mehta AI, Frogale K et al. Analysis of albumin-associated peptides and proteins from ovarian cancer patients. Clin Chem 2005;51:1933-45.
25. Illei GG, Tackey E, Lapteva L, Lipsky PE. Biomarkers in systemic lupus erythematosus: II. Markers of disease activity. Arthritis Rheum 2004;50:2048-65.
26. Avihingsanon Y, Phumesin P, Benjachat T et al. Measurement of urinary chemokine and growth factor messenger RNAs: A noninvasive monitoring in lupus nephritis. Kidney Int 2006;69:747-53.
27. Rovin BH, Song H, Hebert LA et al. Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus. Kidney Int 2005;68:1825-33.
28. Rovin BH, Song H, Birmingham DJ, Hebert LA, Yu CY, Nagaraja HN. Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J Am Soc Nephrol 2005;16:467-73.
29. Oates JC, Varghese S, Bland AM et al. Prediction of urinary protein markers in lupus nephritis. Kidney Int 2005;68:2588-92.
30. Rai AJ, Stemmer PM, Zhang Z et al. Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization-time of flight (SELDI-TOF) mass spectrometry: Multi-institution correlation of spectra and identification of biomarkers. Proteomics 2005;5:3467-74.
31. Semmes OJ, Feng Z, Adam BL et al. Evaluation of serum protein profiling by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry for the detection of prostate cancer: I. Assessment of platform reproducibility. Clin Chem 2005;51:102-12.